Yatharth Hospital & Trauma Care Services Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company has delivered good profit growth of 54.1% CAGR over last 5 years
- Company has consistently been profitable over the last 5 years
- Company has delivered good sales growth of 39.5% CAGR over last 5 years
- Working capital cycle has improved - days down from 318 to 160
- Company comfortably covers its interest (12.9x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Recent results are weak - TTM profit is down 80.4% versus prior year
- Promoter holding has decreased over last 2 years: -10.7pp
- Total debt has risen sharply - up 6080.3% year on year
- Free cash flow has been persistently negative
- Equity base is being diluted - shares outstanding up 47.1%
- Valuation is stretched - P/E of 52.6 is well above its own 5-year median (31.3)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8960.00 | 61.66 | 128831.05 | 0.22 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MAXHEALTH | 1036.50 | 69.24 | 100883.61 | 0.19 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| MANIPALHOS | 729.95 | 107.60 | 96015.96 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| FORTIS | 911.90 | 65.70 | 68844.63 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 780.05 | 213.36 | 67994.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| MEDANTA | 1479.75 | 71.54 | 39786.30 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1888.80 | 47.30 | 38599.67 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| LALPATHLAB | 1919.45 | 59.45 | 32217.74 | 1.07 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| KIMS | 764.80 | 157.23 | 32122.10 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| AGARWALEYE | 514.20 | 109.87 | 16301.49 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 16.14 | 27.75 |
| VIJAYA | 1496.85 | 82.23 | 15417.21 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| YATHARTH | 989.25 | 52.61 | 9531.85 | 0.00 | 454.23 | 8.04 | 3926.54 | 52.33 | 13.30 | 23.35 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,545 | 1,713 | 1,668 | 1,778 | 2,118 | 2,178 | 2,192 | 2,318 | 2,578 | 279 | 320 | 342 | 3,927 | |
| 1,259 | 1,355 | 1,284 | 1,393 | 1,725 | 1,806 | 1,832 | 1,886 | 2,084 | 215 | 246 | 262 | 3,358 | |
| Operating Profit | 286 | 358 | 384 | 385 | 393 | 371 | 359 | 432 | 494 | 65 | 74 | 80 | 569 |
| OPM % | 18.52% | 20.87% | 23.03% | 21.63% | 18.56% | 17.05% | 16.40% | 18.63% | 19.16% | 23.09% | 23.17% | 23.40% | 14.48% |
| 8 | 38 | 54 | 57 | 37 | 30 | 42 | 53 | 93 | 9 | 8 | 7 | 44 | |
| Interest | 59 | 29 | 2 | 4 | 29 | 16 | 21 | 10 | 2 | 0 | 1 | 5 | 66 |
| Depreciation | 69 | 69 | 79 | 77 | 114 | 159 | 169 | 129 | 149 | 19 | 24 | 30 | 282 |
| Profit before Tax | 294 | 396 | 438 | 441 | 430 | 401 | 402 | 485 | 587 | 55 | 57 | 52 | 612 |
| Tax % | 35.18% | 30.25% | 32.65% | 13.06% | 29.27% | 22.80% | 24.07% | 20.21% | 28.37% | 24.75% | 24.54% | 13.96% | 25.79% |
| Net Profit | 190 | 276 | 295 | 383 | 304 | 310 | 305 | 387 | 420 | 41 | 43 | 45 | 454 |
| 2.91 | 3.80 | 3.83 | 4.85 | 3.54 | 3.59 | 3.57 | 4.37 | 4.36 | 4.28 | 4.71 | 4.93 | 4.88 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 102 | 146 | 229 | 401 | 520 | 671 | 886 | 1,207 | 1,334 | |
| 82 | 108 | 161 | 289 | 385 | 489 | 655 | 903 | 1,059 | |
| Operating Profit | 20 | 38 | 68 | 112 | 135 | 182 | 230 | 304 | 276 |
| OPM % | 19.68% | 26.32% | 29.76% | 27.93% | 25.98% | 27.14% | 26.01% | 25.21% | 20.65% |
| 0 | 0 | 1 | 2 | 3 | 16 | 11 | 26 | 29 | |
| Interest | 7 | 20 | 20 | 23 | 23 | 11 | 12 | 19 | 13 |
| Depreciation | 8 | 21 | 21 | 28 | 28 | 29 | 57 | 88 | 101 |
| Profit before Tax | 5 | -2 | 28 | 63 | 88 | 157 | 172 | 224 | 225 |
| Tax % | 20.71% | 17.48% | 30.35% | 30.02% | 24.99% | 27.01% | 23.98% | 23.82% | 22.49% |
| Net Profit | 4 | -2 | 20 | 44 | 66 | 114 | 131 | 170 | 174 |
| EPS | 0.63 | -0.20 | 2.77 | 6.78 | 10.09 | 13.33 | 13.55 | 18.20 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 39%
- 3 Years:
- 32%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 57%
- 3 Years:
- 39%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 37%
- 1 Year:
- 22%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 27%
- 3 Years:
- 14%
- Last Year:
- 10%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 66 | 66 | 86 | 96 | 96 |
| Minority Interest | 3 | 8 | 8 | 0 | 0 | 0 | 32 | 27 |
| 39 | 38 | 56 | 51 | 117 | 788 | 1,509 | 1,684 | |
| 162 | 171 | 173 | 226 | 265 | 75 | 8 | 266 | |
| Trade Payables | 13 | 14 | 17 | 20 | 17 | 29 | 29 | 110 |
| 24 | 41 | 38 | 57 | 13 | 30 | 38 | 72 | |
| Total Liabilities | 257 | 287 | 309 | 421 | 478 | 1,009 | 1,713 | 2,255 |
| 164 | 189 | 251 | 303 | 299 | 442 | 605 | 1,250 | |
| Capital Work in Progress | 65 | 62 | 0 | 0 | 0 | 0 | 222 | 102 |
| 0 | 0 | 0 | 0 | 0 | 0 | 74 | 2 | |
| 2 | 3 | 3 | 5 | 6 | 8 | 21 | 21 | |
| 0 | 0 | 0 | 0 | 0 | 227 | 302 | 375 | |
| Cash & Bank | 0 | 2 | 5 | 12 | 38 | 239 | 441 | 263 |
| 25 | 31 | 49 | 100 | 135 | 93 | 48 | 242 | |
| Total Assets | 257 | 287 | 309 | 421 | 478 | 1,009 | 1,713 | 2,255 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 20 | 42 | 46 | 73 | 101 | -3 | 131 | 205 | |
| Cash from Investing | -78 | -43 | -21 | -52 | -20 | -226 | -388 | -598 |
| Cash from Financing | 47 | 5 | -19 | -1 | -18 | 304 | 509 | 254 |
| -13 | 1 | 3 | 7 | 26 | 75 | 253 | -140 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-04 - We hereby submit the Newspaper Publication of the Notice for the 19th Annual General Meeting of the Company, along with the e-voting information.
2026-09-03 - We hereby submit Business Responsibility and Sustainability Reporting (BRSR) of the Company for FY 2025-26.
2026-09-03 - We hereby submit Notice of 19th Annual General Meeting of the Company.
2026-08-28 - The Exchange has sought clarification from Yatharth Hospital & Trauma Care Services Limited with respect to recent news item captioned Aster, Advent eye controlling stake in Yatharth Hospital, says report; shares rise 4.5%. The response from the Company is attached.
2026-08-28 - The Exchange has sought clarification from Yatharth Hospital & Trauma Care Services Limited with respect to recent news item captioned Aster, Advent eye controlling stake in Yatharth Hospital, says report; shares rise 4.5%. The response from the Company is awaited.
2026-08-22 - We hereby submit Newspaper Advertisement for information regarding the 19th Annual General Meeting of the Company.
2026-08-21 - We hereby submit Intimation of the date of 19th Annual General Meeting of the Company.
2026-08-18 - We hereby submit Earnings Call Transcript Q1FY27.
2026-08-13 - We hereby submit Monitoring Agency Report for the quarter ended June 30, 2026 (IPO).
News
Recent coverage and analyst commentary for YATHARTH
Loading news…
AI Stock Analyst
Yatharth Hospital & Trauma Care Services Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account